Schizophrenia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 45 years old
- People who are able to give written consent in English
- People who are currently taking prescribed medications may still be eligible
- People who have been diagnosed with schizophrenia or schizoaffective disorder (as defined by DSM-IV criteria)
- People with normal vision, either naturally or with corrective lenses such as glasses or contacts
- People who are physically able to participate in a regular exercise program
Who may not be able to join:
- People who have a history of organic brain conditions, such as dementia, severe head injury, or developmental disorders including autism, intellectual disability, or Down's Syndrome
- People who have been diagnosed with a substance dependence disorder in the past 12 months (not including tobacco)
- People who have any other psychiatric diagnosis (beyond schizophrenia or schizoaffective disorder) as defined by DSM-IV criteria
- People who have a history of chest pain (angina), heart attack, or mini-strokes (transient ischemic attacks)
- People who are unable to move around independently or who use a limb prosthesis
- People who have a history of a severe head injury that caused loss of consciousness for more than 5 minutes
- People who cannot safely undergo brain imaging scans — for example, those with metal implants, non-removable braces, severe claustrophobia, current pregnancy, or surgery within the past 6 months
- People who are already participating in a regular exercise program
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Donna J Lang, PhD, University of British Columbia, Dept. of Radiology
Phone: 604-875-2000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Increase hippocampal volume with aerobic training in schizophrenic and healthy volunteers.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.